General practice study of Nicotine Replacement Therapy (NRT) assisted smoking cessation

ISRCTN ISRCTN05689186
DOI https://doi.org/10.1186/ISRCTN05689186
Protocol serial number N0032117035
Sponsor University of Oxford (UK)
Funder Cancer Research UK (CRUK) (UK)
Submission date
12/10/2005
Registration date
16/11/2005
Last edited
20/12/2011
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Mental and Behavioural Disorders
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Michael Murphy
Scientific

Smoking Research Group
Department of clinical Pharmacology
University of Oxford
Radcliffe Infirmary
Woodstock Road
Oxford
OX2 6HE
United Kingdom

Study information

Primary study designInterventional
Study designRandomised controlled trial
Secondary study designRandomised controlled trial
Scientific title
Study acronymPatch In Practice (PIP)
Study objectives1. Assess whether extremes of behavioural support make a difference to quit rates
2. Study whether an individual's response to NRT is influenced by genetic constitution
3. Describe the relationship between nicotine load whilst smoking and that derived from transdermal patch
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedSmoking cessation
InterventionPIP is an open randomised controlled trial of two levels of behavioural support. One of the aims of the study is to assess response of moderately addicted smokers making a Nicotine Replacement Therapy (NRT) assisted quit attempt when randomised to low or moderate behavioural support within general practice.
Intervention typeDrug
PhaseNot Specified
Drug / device / biological / vaccine name(s)Nicotine
Primary outcome measure(s)

Continuous abstinence by self-report and carbon dioxide at 1 week, 4 weeks, and 12 weeks in relation to genotype and 4 weeks for replacement.

Key secondary outcome measure(s)

1. Continuous abstinence at 1, 3, 6 and 12 months
2. Point prevalence abstinence at 1 week, 4 weeks, 3, 6 and 12 months by self report

Completion date31/03/2006

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexAll
Target sample size at registration1000
Key inclusion criteria1. Greater than 18 years of age
2. Smoke 10 or more cigarettes per day
3. Wish to try to give up completely
Key exclusion criteria1. Pregnant or breast feeding
2. Using NRT or Zyban
Date of first enrolment01/08/2002
Date of final enrolment31/03/2006

Locations

Countries of recruitment

  • United Kingdom
  • England

Study participating centre

Smoking Research Group
Oxford
OX2 6HE
United Kingdom

Results and Publications

Individual participant data (IPD) Intention to shareNo
IPD sharing plan summary
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article Results 01/10/2007 Yes No